Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Beigene Ltd ADR (NQ: BGNE )

317.25 USD UNCHANGED
Streaming Delayed Price Updated: 5:35 PM EST, Dec 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Beigene Ltd ADR

< Previous 1 2 3 4 5 6 Next >
Noteworthy ETF Inflows: IXUS, SE, BGNE, JD
Symbols mentioned in this story: IXUS, SE, BGNE, JD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt ... 
Tags ONCY SURF ADCT
From Benzinga
Week In Review: BeiGene Raises $3.5 Billion In Shanghai STAR Board IPO
Beijing's BeiGene announced its Shanghai STAR Exchange IPO will raise $3.5 billion in gross proceeds for the company, more than the predictions of $3 billion. It is the third listing for the company,... 
Tags Pharma/Biotech Market News Stocks / Equities
From TalkMarkets
BeiGene - EUSA Pharma's Siltuximab Approved In China For Multicentric Castleman Disease
TheChina National Medical Products Administration has approvedBeiGene Ltd(NASDAQ: BGNE) /EUSA Pharma (UK) ... 
Tags Market News News BGNE
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Protagonist to Discontinue ... 
Tags General FDA PTGX
From Benzinga
Week In Review: Shanghai's Zenas Acquires CD19 Antibody From Xenco In $480 Million Deal
In a $480 million deal, Zenas acquired global rights to a bifunctional antibody from Xencor that targets CD19. Instead of an upfront payment, Zenas will issue a warrant granting Xencor the right to... 
Tags Pharma/Biotech Market News Stocks / Equities
From TalkMarkets
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Puma Biotech Announces ... 
Tags CNTG Offerings FDA
From Benzinga
BeiGene's Brukinsa Approved In Europe For Rare Type Of Blood Cancer
TheEuropean Commission has approvedBeiGene Ltd's(NASDAQ: BGNE) BRUKINSA (zanubrutinib) for Waldenstr's ... 
Tags Market News News European Medicines Agency
From Benzinga
Week In Review: BeiGene Cleared To Stage $3 Billion IPO On Shanghai STAR Exchange
Beijing's BeiGene was approved to stage a $3 billion IPO on Shanghai’s STAR Exchange, the company's third listing. Previously, the company completed an $182 million IPO on the NASDAQ in 2016 and a $900... 
Tags Stocks / Equities Market News Pharma/Biotech
From TalkMarkets
Beigene Scores Relative Strength Rating Upgrade; Hits Key Threshold
A Relative Strength Rating upgrade for Beigene shows improving technical performance. 
From Investor's Business Daily
Stocks With Rising Relative Price Strength: Beigene
Beigene sees its Relative Strength Rating enter the 80-plus level. 
From Investor's Business Daily
Beigene Earns Technical Rating Upgrade
Beigene shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Week In Review: Two China Affiliated Biopharmas Raise $585 Million In IPOs
LianBio raised $325 million in its Nasdaq IPO at a market capitalization of $1.9 billion to support its drug in-licensings for China. Beijing Clover Biopharma also completed a $260 million IPO in Hong... 
Tags Pharma/Biotech Stocks / Equities Market News
From TalkMarkets
EEMV, BGNE, BAP, ZTO: ETF Outflow Alert
Symbols mentioned in this story: EEMV, BGNE, BAP, ZTO Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Here's My Top Value Stock To Buy Right Now
EXEL is working on further expanding cabozantinib’s label. It is currently evaluating the drug as a single agent and in combination with immune checkpoint inhibitors across various indications. 
Tags Pharma/Biotech Market News Stocks / Equities
From TalkMarkets
We Did The Math QQQJ Can Go To $40
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
2 Growth Stocks That Could Deliver 1,000% Returns
These two low-priced biotech stocks could produce life-changing returns for early shareholders. 
Tags Market News MREO ABT
From Motley Fool
Stocks Showing Rising Market Leadership: Beigene Earns 84 RS Rating
A Relative Strength Rating upgrade for Beigene shows improving technical performance. 
From Investor's Business Daily
Wednesday Market Coverage
Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal. 
Tags Stocks / Equities Market News
From TalkMarkets
IBD Rating Upgrades: Beigene Shows Improved Technical Strength
Beigene shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Week In Review: Hansoh Signs $456 Million Deal For siRNA Products
Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to... 
Tags Healthcare Pharma/Biotech Market News
From TalkMarkets
2 Penny Stocks That Could Soar Soon
These two tiny drugmakers might be hidden gems. 
Tags RHHBY LPTX Market News
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021
Upgrades For Callaway Golf Co (NYSE:ELY), Compass Point upgraded the previous rating of Neutral to Buy. Callaway Golf earned $0.36 in ... 
Tags ZH Downgrades ACT
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ALKS ABIO IBB
From Benzinga
3 Biotech Stocks That Surged in September
Find out why last month was a big one for these three drugmakers. 
Tags BAYR/Y BLU BGNE
From Motley Fool
This Potential Indication Could Be a Winner for Novartis
The U.S. Food and Drug Administration accepted Novartis' filing for tislelizumab to treat esophageal cancer. 
Tags BGNE NVS Market News
From Motley Fool
Notable Beigene Insider Trades $3.11 Million In Company Stock
Jane Huang, Cmo And Hematology at Beigene (NASDAQ:BGNE), made a large buy and sell of company shares on September 20, according to a new ... 
Tags BGNE Benzinga Jane Huang
From Benzinga
48 Biggest Movers From Friday
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded ... 
Tags OSUR EVLO IPSC
From Benzinga
Why BeiGene Shares Are Rising
Beigene Ltd (NASDAQ: BGNE)shares are trading higher by 3.8% at $400 after the company announced it received a positive CHMP ... 
Tags News Market News Benzinga
From Benzinga
Why BeiGene's Shares Jumped on Friday
The Chinese pharmaceutical company is racking up approvals for its lead oncology drug, Brukinsa. 
Tags ABBV BGNE Market News
From Motley Fool
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.